Ipilimumab and Nivolumab for Treatment of Eyelid Spindle Cell Melanoma. Shoji MK, Rong AJ. Am J Ophthalmol 2023 Feb 17:S0002-9394(23)00064.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shoji MK, Rong AJ. Ipilimumab and Nivolumab for Treatment of Eyelid Spindle Cell Melanoma. Am J Ophthalmol 2023 Feb 17:S0002-9394(23)00064.
PMID: 36801380